HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $494,392 | -45.2% | 5,519 | -47.9% | 0.00% | -50.0% |
Q2 2023 | $902,399 | +18.3% | 10,599 | +9.3% | 0.00% | 0.0% |
Q4 2022 | $762,512 | +388.8% | 9,695 | +358.6% | 0.00% | +300.0% |
Q3 2022 | $156,000 | -44.1% | 2,114 | -52.2% | 0.00% | -50.0% |
Q1 2022 | $279,000 | -0.7% | 4,420 | -16.6% | 0.00% | -33.3% |
Q4 2021 | $281,000 | -24.1% | 5,299 | +1.2% | 0.00% | -40.0% |
Q3 2021 | $370,000 | -23.1% | 5,236 | -27.4% | 0.01% | -28.6% |
Q2 2021 | $481,000 | -20.1% | 7,212 | +32.9% | 0.01% | -30.0% |
Q1 2021 | $602,000 | -9.9% | 5,425 | -3.6% | 0.01% | -23.1% |
Q4 2020 | $668,000 | -37.2% | 5,629 | -53.8% | 0.01% | -43.5% |
Q3 2020 | $1,063,000 | -46.3% | 12,182 | -29.2% | 0.02% | -74.2% |
Q4 2019 | $1,978,000 | -16.7% | 17,218 | -8.6% | 0.09% | +67.9% |
Q3 2019 | $2,375,000 | -2.7% | 18,831 | -7.2% | 0.05% | -11.7% |
Q2 2019 | $2,442,000 | +15.0% | 20,293 | +9.5% | 0.06% | -25.0% |
Q3 2018 | $2,123,000 | +43.3% | 18,532 | +12.2% | 0.08% | +19.4% |
Q2 2018 | $1,481,000 | – | 16,510 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |